| Solution Information | help | |
| Enzyme: | Galanin receptor type 2 | |
| inhibitor: | BDBM42053 | |
| substrate: | n/a | |
| Solution Type: | Aqueous | |
| pH at Preparation: | n/a | |
| Temp. Prep.: | n/a | |
| Comments: | Assay Overview: The purpose of this counterscreen assay is to determine whether compounds identified as active in a previous set of experiments entitled, "Dose Response cell-based high-throughput screening assay to identify antagonists of galanin receptor 2 (GALR2)" (PubChem AID 1225) were assay artifact due to non-specific activation of the beta-lactamase reporter gene or interference with the assay readout. Test compounds were assayed in triplicate in a 10-point, 1:3 dilution series starting at a nominal test concentration of 42 uM. In this assay a cell line stably expressing the beta-lactamase (BLA) reporter gene under control of the Nuclear Factor of Activated T-cells (NFAT) promoter was used. Changes in BLA expression are monitored by measuring fluorescence resonance energy transfer (FRET) of a cleavable fluorogenic cell permeable BLA substrate. As designed, a compound that prevents FRET is considered a non-selective BLA inhibitor. Protocol Summary: Chinese Hamster Ovar | |
| If you find an error in this entry please send us an E-mail | ||